Jugular Ultrasound for Spinal Hypotension
Launched by CAIRO UNIVERSITY · May 23, 2025
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to predict and manage low blood pressure that can happen after spinal anesthesia, especially in older patients. Low blood pressure after this type of anesthesia can be quite common, affecting up to 73% of elderly patients. The researchers believe that using ultrasound to measure the internal jugular vein (a blood vessel in the neck) could help doctors assess a patient's blood volume more accurately before surgery, which may help reduce risks like heart attacks or strokes during and after surgery.
To participate in this study, you must be over 65 years old and be scheduled for an elective surgery that requires spinal anesthesia while lying on your back. However, if you have certain health issues, such as obesity (a body mass index over 35), uncontrolled high blood pressure, or other specific heart problems, you may not qualify. The trial is not yet recruiting participants, but if you are eligible and choose to join, you can expect to undergo a simple ultrasound test before your surgery to help ensure your safety and well-being during the procedure.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • • Age \> 65 years old.
- • Both sexes.
- • American Society of Anesthesiologists (ASA) physical status I, II , III.
- • Elective surgeries Under spinal anesthesia in the supine position.
- Exclusion Criteria:
- • • Body Mass Index (BMI) more than 35 kg/m2.
- • Uncontrolled hypertension.
- • Ejection fraction less than 40%
- • Emergency cases.
- • Absolute or relative contraindications to spinal anesthesia.
- • Patients with a baseline arterial systolic blood pressure (SBP) less than 90 mmHg or mean arterial blood pressure (MBP) less than 65 mmHg.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported